Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
15 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/15/2946296/0/en/Replimune-Presents-Primary-Analysis-Data-from-IGNYTE-Clinical-Trial-of-RP1-Combined-with-Nivolumab-in-Anti-PD1-Failed-Melanoma-at-European-Society-for-Medical-Oncology-ESMO-Congres.html
09 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/09/2942760/0/en/Replimune-Announces-Positive-Pre-BLA-Meeting-with-FDA-and-Confirms-BLA-Submission-On-Track-for-2H-2024.html
05 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/05/2941320/0/en/Stockholders-Vote-to-Elect-Madhavan-Balachandran-to-Board-of-Directors.html
22 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/22/2934171/0/en/Replimune-Announces-Late-Breaking-Abstract-of-IGNYTE-Clinical-Trial-Primary-Analysis-Selected-for-Oral-Presentation-at-the-European-Society-for-Medical-Oncology-ESMO-Congress-2024.html
13 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/13/2929115/0/en/Replimune-Announces-First-Patient-Dosed-in-IGNYTE-3-Clinical-Trial-in-Advanced-Melanoma.html
08 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/08/2926869/0/en/Replimune-Reports-Fiscal-First-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?